Skip to Main Content

Editors note: A recording of the conversation is embedded below.

Every week STAT+ subscribers get access to exclusive content with biotech, pharma, and health tech leaders. This week, STAT general assignment reporter and associate editorial director of events Nicholas St. Fleur will be joined by STAT science writer Megan Molteni. They will be discussing Molteni’s recent report on Intellia Therapeutics’ positive early data on in vivo CRISPR therapy. They will explore the details of this milestone, what it means for patients, and of course be taking your questions live.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment